Trial Profile
Pilot Study of the Clinical Activity of Eculizumab for Prevention of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2023
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Delayed graft function
- Focus Therapeutic Use
- 02 May 2019 Status changed from recruiting to discontinued.
- 03 May 2014 New trial record